Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2019 Filed May 22, 2019 16:23 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionCommon Stock | 4,400 | $4.63 | $20,372.00 |
DisclosureSEC source: 0001209191-19-031947 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:17 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,400 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-19-031970 · doc4.xml · derivative · entry 5 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,783 Underlying: Common Stock · 4,400 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| May 20, 2019 Filed May 22, 2019 16:23 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,400 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-19-031947 · doc4.xml · derivative · entry 3 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,218 Underlying: Common Stock · 4,400 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:38 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-022543 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:38 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 2,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-022537 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,146 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:37 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-022530 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,528 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:36 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 1,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-022525 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 00:19 UTC |
Payne FletcherChief Financial Officer
|
GrantCommon Stock | 1,002 | $7.04 | $7,054.08 |
DisclosureSEC source: 0001209191-19-009885 · doc4.xml · nonDerivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,731 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 11, 2019. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:01 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantCommon Stock | 350 | $7.04 | $2,464.00 |
DisclosureSEC source: 0001209191-19-009705 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,167 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 11, 2019. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:00 UTC |
Levy HowardChief Medical Officer
|
GrantCommon Stock | 2,485 | $7.04 | $17,494.40 |
DisclosureSEC source: 0001209191-19-009704 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,867 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 11, 2019. Read SEC document |
| February 04, 2019 Filed Feb 4, 2019 21:52 UTC |
Payne FletcherChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,503 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-19-006858 · doc4.xml · derivative · entry 2 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,497 Underlying: Common Stock · 1,503 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| February 04, 2019 Filed Feb 4, 2019 21:52 UTC |
Payne FletcherChief Financial Officer
|
Exercise / conversionCommon Stock | 1,503 | $4.63 | $6,958.89 |
DisclosureSEC source: 0001209191-19-006858 · doc4.xml · nonDerivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:53 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-19-006862 · doc4.xml · derivative · entry 2 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 1,500 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:53 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $4.63 | $6,945.00 |
DisclosureSEC source: 0001209191-19-006862 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:51 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,729 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-19-006857 · doc4.xml · derivative · entry 2 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,271 Underlying: Common Stock · 5,729 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017 Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:51 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,729 | $4.63 | $26,525.27 |
DisclosureSEC source: 0001209191-19-006857 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 23:58 UTC |
USMAN NASSIMDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0001209191-19-005668 · doc4.xml · derivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2029-01-24 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019. Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 23:54 UTC |
Levy HowardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0001209191-19-005666 · doc4.xml · derivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-01-24 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019. Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 23:56 UTC |
Payne FletcherChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0001209191-19-005667 · doc4.xml · derivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2029-01-24 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:45 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001224 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,672 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:44 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 2,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001221 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,732 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:44 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001219 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:43 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 1,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001218 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,944 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 22:01 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 149 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-18-060006 · doc4.xml · derivative · entry 2 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,118 Underlying: Common Stock · 149 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 22:01 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionCommon Stock | 149 | $4.63 | $689.87 |
DisclosureSEC source: 0001209191-18-060006 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2018 Filed Nov 16, 2018 22:56 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 173 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-18-059044 · doc4.xml · derivative · entry 3 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,267 Underlying: Common Stock · 173 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| November 16, 2018 Filed Nov 16, 2018 22:56 UTC |
Levy HowardChief Medical Officer
|
SaleCommon Stock | 173 | $11.00 | $1,903.00 |
DisclosureSEC source: 0001209191-18-059044 · doc4.xml · nonDerivative · entry 2 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 F1 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018. Read SEC document |
| November 16, 2018 Filed Nov 16, 2018 22:56 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionCommon Stock | 173 | $4.63 | $800.99 |
DisclosureSEC source: 0001209191-18-059044 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 01:41 UTC |
HILL STEPHEN ADirector
|
Disposition to issuerCommon Stock | 190 | $10.07 | $1,913.30 |
DisclosureSEC source: 0001209191-18-049987 · doc4.xml · nonDerivative · entry 1 HILL STEPHEN A · CIK 0001237404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190 Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 21:48 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001209191-18-044791 · doc4.xml · derivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-07-30 F1 · derivative.exercise_date: Award vests monthly over four (4) years starting June 13, 2018. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 21:48 UTC |
Payne FletcherChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001209191-18-044790 · doc4.xml · derivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-07-30 F1 · derivative.exercise_date: Award vests monthly over four (4) years starting June 13, 2018. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 21:47 UTC |
Levy HowardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001209191-18-044788 · doc4.xml · derivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-07-30 F1 · derivative.exercise_date: Award vests monthly over four (4) years starting June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:57 UTC |
Williams EddieDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038139 · doc4.xml · derivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:56 UTC |
Richard John PDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038138 · doc4.xml · derivative · entry 1 Richard John P · CIK 0001296528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:53 UTC |
LAWLOR AUGUSTINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038137 · doc4.xml · derivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:53 UTC |
Hunt AndreaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038136 · doc4.xml · derivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:52 UTC |
DESOUZA ERROL BDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038134 · doc4.xml · derivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:52 UTC |
HILL STEPHEN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $24.94 | $0.00 |
DisclosureSEC source: 0001209191-18-038135 · doc4.xml · derivative · entry 1 HILL STEPHEN A · CIK 0001237404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing 06/13/2018. Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:58 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,560 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-18-028135 · doc4.xml · derivative · entry 2 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,440 Underlying: Common Stock · 7,560 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. F2 · derivative.expiration_date: Due to clerical error, the expiration date of the grant was erroneously reported on the Form 4 filed July 13, 2017 as "07/11/2017". This filing corrects that error. Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:58 UTC |
Levy HowardChief Medical Officer
|
Exercise / conversionCommon Stock | 7,560 | $4.63 | $35,002.80 |
DisclosureSEC source: 0001209191-18-028135 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2018 Filed Apr 12, 2018 00:00 UTC |
USMAN NASSIMDirector · President & CEO
|
GiftCommon Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024695 · doc4.xml · nonDerivative · entry 2 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Usman Family Trust Disclosed balance after: 4,144 F1 · balance_after: Reflects a 1:15 reverse stock split effected on February 10, 2017. Read SEC document |
| April 09, 2018 Filed Apr 12, 2018 00:00 UTC |
USMAN NASSIMDirector · President & CEO
|
GiftCommon Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024695 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 04, 2018 Filed Apr 6, 2018 21:03 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 88 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-18-024224 · doc4.xml · derivative · entry 4 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,912 Underlying: Common Stock · 88 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| April 04, 2018 Filed Apr 6, 2018 21:03 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionCommon Stock | 88 | $4.63 | $407.44 |
DisclosureSEC source: 0001209191-18-024224 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:11 UTC |
Payne FletcherChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 59 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-18-021896 · doc4.xml · derivative · entry 3 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,941 Underlying: Common Stock · 59 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:11 UTC |
Payne FletcherChief Financial Officer
|
Exercise / conversionCommon Stock | 59 | $4.63 | $273.17 |
DisclosureSEC source: 0001209191-18-021896 · doc4.xml · nonDerivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 8, 2018 22:18 UTC |
Flynn James E10% owner · Possible Member of 10% Group
Deerfield Mgmt L.P.10% owner · Possible Member of 10% Group
DEERFIELD MANAGEMENT COMPANY, L.P.10% owner · Possible Member of 10% Group
Deerfield Special Situations Fund, L.P.10% owner · Possible Member of 10% Group
|
SaleCommon Stock | 8,123 | $29.03 | $235,810.69 |
DisclosureSEC source: 0001193805-18-000371 · e617783_4-catalyst.xml · nonDerivative · entry 5 Flynn James E · CIK 0001352546 · 10% owner · Possible Member of 10% Group Deerfield Mgmt L.P. · CIK 0001010823 · 10% owner · Possible Member of 10% Group DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · 10% owner · Possible Member of 10% Group Deerfield Special Situations Fund, L.P. · CIK 0001354395 · 10% owner · Possible Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Through Deerfield Special Situations Fund, L.P. Disclosed balance after: 1,113,222 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.75, inclusive. F4 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (the "Fund"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F5 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 08, 2018 Filed Mar 8, 2018 22:18 UTC |
Flynn James E10% owner · Possible Member of 10% Group
Deerfield Mgmt L.P.10% owner · Possible Member of 10% Group
DEERFIELD MANAGEMENT COMPANY, L.P.10% owner · Possible Member of 10% Group
Deerfield Special Situations Fund, L.P.10% owner · Possible Member of 10% Group
|
SaleCommon Stock | 1,194 | $30.00 | $35,820.00 |
DisclosureSEC source: 0001193805-18-000371 · e617783_4-catalyst.xml · nonDerivative · entry 4 Flynn James E · CIK 0001352546 · 10% owner · Possible Member of 10% Group Deerfield Mgmt L.P. · CIK 0001010823 · 10% owner · Possible Member of 10% Group DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · 10% owner · Possible Member of 10% Group Deerfield Special Situations Fund, L.P. · CIK 0001354395 · 10% owner · Possible Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Through Deerfield Special Situations Fund, L.P. Disclosed balance after: 1,121,345 F4 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (the "Fund"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F5 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 08, 2018 Filed Mar 21, 2018 20:12 UTC Amendment |
Flynn James E10% owner · Possible Member of 10% Group
Deerfield Mgmt L.P.10% owner · Possible Member of 10% Group
DEERFIELD MANAGEMENT COMPANY, L.P.10% owner · Possible Member of 10% Group
Deerfield Special Situations Fund, L.P.10% owner · Possible Member of 10% Group
DEERFIELD PARTNERS, L.P.10% owner · Possible Member of 10% Group
|
SaleCommon Stock | 2,233 | $29.03 | $64,823.99 |
DisclosureSEC source: 0001193805-18-000436 · e617828_4a-catalyst.xml · nonDerivative · entry 10 Flynn James E · CIK 0001352546 · 10% owner · Possible Member of 10% Group Deerfield Mgmt L.P. · CIK 0001010823 · 10% owner · Possible Member of 10% Group DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · 10% owner · Possible Member of 10% Group Deerfield Special Situations Fund, L.P. · CIK 0001354395 · 10% owner · Possible Member of 10% Group DEERFIELD PARTNERS, L.P. · CIK 0001301041 · 10% owner · Possible Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Through Deerfield Special Situations Fund, L.P. Disclosed balance after: 305,965 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.75, inclusive. F4 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. and Deerfield Partners, L.P. (the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F5 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. F6 · ownership.nature: This Amendment to the Form 4 filed with the Commission on March 8, 2018 (the "Original Filing") is being filed to correctly report the identity of the direct beneficial owners of shares sold on March 6, 2018, March 7, 2018 and March 8, 2018 (as well as the direct holder of shares beneficially owned by the applicable Reporting Persons following such sales) which were incorrectly reported on the March 8, 2018 Form 4 report. The aggregate number of shares sold by the Funds and the aggregate number of shares beneficially owned by the Reporting Persons, as reported in the Original Filing, remains unchanged. Read SEC document |
| March 08, 2018 Filed Mar 21, 2018 20:12 UTC Amendment |
Flynn James E10% owner · Possible Member of 10% Group
Deerfield Mgmt L.P.10% owner · Possible Member of 10% Group
DEERFIELD MANAGEMENT COMPANY, L.P.10% owner · Possible Member of 10% Group
Deerfield Special Situations Fund, L.P.10% owner · Possible Member of 10% Group
DEERFIELD PARTNERS, L.P.10% owner · Possible Member of 10% Group
|
SaleCommon Stock | 5,890 | $29.03 | $170,986.70 |
DisclosureSEC source: 0001193805-18-000436 · e617828_4a-catalyst.xml · nonDerivative · entry 9 Flynn James E · CIK 0001352546 · 10% owner · Possible Member of 10% Group Deerfield Mgmt L.P. · CIK 0001010823 · 10% owner · Possible Member of 10% Group DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · 10% owner · Possible Member of 10% Group Deerfield Special Situations Fund, L.P. · CIK 0001354395 · 10% owner · Possible Member of 10% Group DEERFIELD PARTNERS, L.P. · CIK 0001301041 · 10% owner · Possible Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Through Deerfield Partners, L.P. Disclosed balance after: 807,257 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.75, inclusive. F4 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. and Deerfield Partners, L.P. (the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F5 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. F6 · ownership.nature: This Amendment to the Form 4 filed with the Commission on March 8, 2018 (the "Original Filing") is being filed to correctly report the identity of the direct beneficial owners of shares sold on March 6, 2018, March 7, 2018 and March 8, 2018 (as well as the direct holder of shares beneficially owned by the applicable Reporting Persons following such sales) which were incorrectly reported on the March 8, 2018 Form 4 report. The aggregate number of shares sold by the Funds and the aggregate number of shares beneficially owned by the Reporting Persons, as reported in the Original Filing, remains unchanged. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.